CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 24 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $531,000 | -55.6% | 32,100 | -53.5% | 0.01% | -53.3% |
| Q1 2019 | $1,195,000 | -2.0% | 69,100 | 0.0% | 0.02% | -6.2% |
| Q4 2018 | $1,220,000 | -2.7% | 69,100 | 0.0% | 0.02% | +33.3% |
| Q3 2018 | $1,254,000 | -7.2% | 69,100 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $1,351,000 | +11.4% | 69,100 | 0.0% | 0.01% | +7.7% |
| Q1 2018 | $1,213,000 | +54.7% | 69,100 | 0.0% | 0.01% | +62.5% |
| Q4 2017 | $784,000 | +6.5% | 69,100 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $736,000 | +21.7% | 69,100 | 0.0% | 0.01% | +14.3% |
| Q2 2017 | $605,000 | +33.8% | 69,100 | +80.4% | 0.01% | +40.0% |
| Q1 2017 | $452,000 | -10.0% | 38,300 | 0.0% | 0.01% | -28.6% |
| Q4 2016 | $502,000 | -9.5% | 38,300 | 0.0% | 0.01% | -12.5% |
| Q3 2016 | $555,000 | – | 38,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|